In-Depth Insights into the Hemoglobin Testing Market: Growth, Trends, and Opportunities for 2025-2034
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the hemoglobin testing market size evolved in recent years?
The size of the hemoglobin testing market has seen significant expansion in recent years. A rise from $2.64 billion in 2024 to $2.81 billion in 2025 is expected, with a compound annual growth rate (CAGR) of 6.5%. The surge observed in the historical period can be tied to factors such as anemia prevalence, initiatives focusing on maternal health, blood donation drives, management of chronic diseases, and worldwide health awareness campaigns.
What are the predictions for the hemoglobin testing market size in the coming years?
The market for hemoglobin testing is anticipated to experience robust expansion in the coming years, growing to a projected “$3.96 billion by 2029 with a compound annual growth rate (CAGR) of 8.9%. The projected growth during this period can be linked to several factors including increased healthcare investment, incorporation into the management of chronic illnesses, the broadening of point-of-care testing, a heightened emphasis on preventive healthcare, and readiness for global health pandemics. Key trends for this forecast period include a shift towards telemedicine and remote patient monitoring, progress in technology, the rise of home-testing kits, coordination with electronic health records (EHR), and a focus on non-invasive procedures.
Get your hemoglobin testing market report here!
https://www.thebusinessresearchcompany.com/report/hemoglobin-testing-global-market-report
What key factors are fueling the growth of the hemoglobin testing market?
The increasing prevalence of chronic diseases like diabetes is forecasted to fuel the expansion of the hemoglobin testing sector. Diabetes is a long-term disease that develops when either the pancreas is unable to produce adequate insulin, or the body cannot effectively use the insulin that is produced. Hemoglobin A1c tests (HbA1c) are employed to keep track of glucose levels in people with diabetes and have been endorsed by the American Diabetes Association as a good alternative for fasting blood glucose to diagnose diabetes. For example, the US Census Bureau, a department of the Federal Statistical System of the United States, noted in November 2022 that over 34 million Americans have diabetes, and another 88 million are at risk. Furthermore, in December 2021, the IDF Diabetes Atlas 10th edition by the International Diabetes Federation, a global diabetes community based in Belgium, reported that in 2021, 536,000 individuals were suffering from diabetes, a number expected to increase to 642,800 by 2030. By 2045, this figure will reach 783,700 on a global scale. As such, the growing prevalence of chronic diseases like anemia and diabetes will promote growth in the hemoglobin testing device market.
How is the global hemoglobin testing market divided into key segments?
The hemoglobin testing market covered in this report is segmented –
1) By Product: Reagents And Consumables, Equipment
2) By Technology: Chromatography, Immunoassay, Spectrophotometry, Other Technologies
3) By End User: Hospitals, Clinics, Laboratories, Home Care Settings, Blood Banks, Other End Users
Subsegments:
1) By Reagents And Consumables: Hemoglobin Testing Kits, Control Solutions, Test Strips, Quality Control Products
2) By Equipment: Hemoglobin Meters, Analyzers, Point-Of-Care Devices, Laboratory Equipment
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10059&type=smp
Who are the key firms paving the way for growth in the hemoglobin testing market?
Major companies operating in the hemoglobin testing market include Abbott Laboratories Inc., Bayer Medical Care Inc., Danaher Corporation, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche AG, Bio-Rad Laboratories Inc., Daiichi Sankyo Inc., ACON Laboratories Inc., DiaSys Diagnostic Systems GmbH, EKF Diagnostics Holdings PLC, Epinex Diagnostics Inc., Erba Diagnostics Inc., ARKRAY Inc., Beckman Coulter Diagnostics Ltd., Diazyme Laboratories Inc., Radiometer A/S, Sysmex Corporation, BioMedomics Inc., Hemosure Inc., Humasis Co. Ltd., Immunostics Inc., LifeSign LLC, Medix Biochemica Oy AB, NanoenTek Inc., Nova Biomedical Corp., Siemens Healthcare GmbH, Mindray Medical International Limited, Nihon Kohden Corporation, Tosoh Corporation
Which trends are expected to transform the hemoglobin testing market?
Top firms in the hemoglobin testing market are creating cutting-edge fingerstick blood tests, making it easier for patients to keep track of their hemoglobin levels at home, enabling early anemia detection, and promoting overall health management. Fingerstick blood test solutions are novel techniques that involve a simple prick to the finger for blood sample collection, making diagnostic testing efficient and less intrusive. For example, in February 2024, health technology firm Sanguina Inc., based in the USA, introduced AnemoCheck Home, the first FDA-approved home hemoglobin test kit. AnemoCheck Home is an original test solution configured to offer precise hemoglobin measurements with a basic finger prick. The user-friendly kit is equipped with everything required, like a testing device and step-by-step instructions, enabling anyone to perform the test without requiring a lab visit. Moreover, AnemoCheck Home not only allows patients to regularly track their hemoglobin levels but also aids in the early identification of potential health problems such as anemia.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10059
What regions are contributing significantly to the growth of the hemoglobin testing market?
Asia-Pacific was the largest regions in the hemoglobin testing market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global hemoglobin testing market report during the forecast period. The regions covered in the hemoglobin testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Anemia And Other Blood Disorder Drugs Global Market Report 2024
Stem Cell/Cord Blood Banking Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/stem-cell-cord-blood-banking-global-market-report
Blood Transfusion Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
